Roundup Settlement Update: Litigation Paused Until Nov. 2
Roundup Settlement Update: Litigation Paused Until Nov. 2
Introduction
Judge Vince Chhabria, overseeing the Roundup multidistrict litigation docket, in a case management conference held via zoom, indicated that he would retain the stay on the controversial weedkiller's litigation until November 2 and asked the parties to provide an update on the proposed more than $10 billion deal.
The September 24th conference was the result of the concerns raised by plaintiffs' attorneys over the settlement deal, announced this year in June, which plaintiffs believed the manufacturer was trying to revoke its proposal.
In the recent hearing, Judge Chhabria also noted that after the set date of the stay, he could remand cases for trials, likely in California, Nebraska, North Carolina, or Illinois. Kenneth Feinberg, who is mediating the settlement deal, stated that he expects that the manufacturer will soon settle the next set of cases scheduled for trial.
The attorneys involved in the litigation stated that the parties have binding deals to settle about 45,000 of the 125,000 filed and unfiled claims and agreements have been made with each lawyer who took cases to trial.
A week ago, three major law firms, California-based Baum Hedlund Aristei & Goldman law firm, the Andrus Wagstaff firm from Colorado, and the Moore Law Group of Kentucky, representing several plaintiffs involved in the Roundup litigation, indicated that they reached an agreement with the manufacturer and filed a “fully-executed and binding Master Settlement Agreement with Monsanto” in the U.S. District Court for the Northern District of California.
Earlier this month, Bayer had also released a statement indicating that progress has been made in the development of a “revised” plan to resolve potential future Roundup litigation, which will be finalized over the coming weeks and will be followed by a motion for preliminary approval of the plan.
Latest News
Study Links Roundup Chemical to Long-Term Brain Damage
A recent study suggests that exposure to the widely used herbicide Roundup, which contains the active ingredient glyphosate, may be…
Zimmer Biomet Gets FDA Approval for Cementless Partial Knee
Zimmer Biomet announced it has received supplemental FDA premarket approval (PMA) for the Oxford Cementless Partial…
Court Names Special Masters for Bard Mesh Claim Settlements
The U.S. District Judge overseeing the federal litigation involving Bard hernia mesh lawsuits has appointed two…